Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Clinical Pathophysiology of Sickle Cell Disease

The Clinical Pathophysiology of Sickle Cell Disease Polymerization of deoxyhemoglobin S within sickle erythrocytes is of cardinal importance to each of the clinical complications of sickle cell anemia. Sickle gene expression, however, is modulated by a number of pathophysiological mechanisms that generate vast clinical diversity among sickle cell patients. These processes include genotypic variations, modifi­ cations of polymerization, abnormal erythrocyte hydration, membrane defects, and rheologic factors. In many cases it is possible to relate specific pathophysiological mechanisms to particular disease features or to possi­ bilities for therapeutic intervention. INTRODUCTION The clinical manifestations of sickle cell anemia are due ultimately to the poor solubility and intraerythrocytic polymerization of deoxygenated hemoglobin S, the product of inherited sickle cel\ genes (1, 2). It is enigmatic that this seemingly straightforward etiology results in tremendous clinical diversity among sickle cell patients (3). Estimates of disease severity based strictly on predictions of the degree of polymerization apply mainly to the level of chronic hemolytic anemia (4). A more comprehensive understand­ ing of the broader spectrum of disease features is achieved by considering the genetic, molecular, cellular, and rheologic mechanisms that modify sickle gene expression. 361 0066-4219/86/0401-0361$02.00 EMBURY The purpose of this review is to describe the pathophysiologic mechan­ isms that mediate http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annual Review of Medicine Annual Reviews

The Clinical Pathophysiology of Sickle Cell Disease

Annual Review of Medicine , Volume 37 (1) – Feb 1, 1986

Loading next page...
 
/lp/annual-reviews/the-clinical-pathophysiology-of-sickle-cell-disease-xwnjkAMqRF

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Annual Reviews
Copyright
Copyright 1986 Annual Reviews. All rights reserved
Subject
Review Articles
ISSN
0066-4219
eISSN
1545-326X
DOI
10.1146/annurev.me.37.020186.002045
pmid
2423018
Publisher site
See Article on Publisher Site

Abstract

Polymerization of deoxyhemoglobin S within sickle erythrocytes is of cardinal importance to each of the clinical complications of sickle cell anemia. Sickle gene expression, however, is modulated by a number of pathophysiological mechanisms that generate vast clinical diversity among sickle cell patients. These processes include genotypic variations, modifi­ cations of polymerization, abnormal erythrocyte hydration, membrane defects, and rheologic factors. In many cases it is possible to relate specific pathophysiological mechanisms to particular disease features or to possi­ bilities for therapeutic intervention. INTRODUCTION The clinical manifestations of sickle cell anemia are due ultimately to the poor solubility and intraerythrocytic polymerization of deoxygenated hemoglobin S, the product of inherited sickle cel\ genes (1, 2). It is enigmatic that this seemingly straightforward etiology results in tremendous clinical diversity among sickle cell patients (3). Estimates of disease severity based strictly on predictions of the degree of polymerization apply mainly to the level of chronic hemolytic anemia (4). A more comprehensive understand­ ing of the broader spectrum of disease features is achieved by considering the genetic, molecular, cellular, and rheologic mechanisms that modify sickle gene expression. 361 0066-4219/86/0401-0361$02.00 EMBURY The purpose of this review is to describe the pathophysiologic mechan­ isms that mediate

Journal

Annual Review of MedicineAnnual Reviews

Published: Feb 1, 1986

There are no references for this article.